Global Point of Care Rapid Diagnosis Market Growth 2023-2029

Global Point of Care Rapid Diagnosis Market Growth 2023-2029

Point of Care Rapid Diagnosis is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.This contrasts with the historical pattern in which testing was wholly or mostly confined to the medical laboratory, which entailed sending off specimens away from the point of care and then waiting hours or days to learn the results. The driving notion behind Point of Care Rapid Diagnosis is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for better immediate clinical management decisions to be made. Point of Care Rapid Diagnosis includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, Sepsis Testing, Upper Respiratory Tract Infections Testing, Antibiotic Resistance Testing, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening. Point of Care Rapid Diagnosis is often accomplished through the use of transportable, portable, and handheld instruments and test kits.Small bench analyzers or fixed equipment can also be used when a handheld device is not available—the goal is to collect the specimen and obtain the results in a very short period of time at or near the location of the patient so that the treatment plan can be adjusted as necessary before the patient leaves.Cheaper, faster, and smarter Point of Care Rapid Diagnosis devices have increased the use of Point of Care Rapid Diagnosis approaches by making it cost-effective for many diseases.

LPI (LP Information)' newest research report, the “Point of Care Rapid Diagnosis Industry Forecast” looks at past sales and reviews total world Point of Care Rapid Diagnosis sales in 2022, providing a comprehensive analysis by region and market sector of projected Point of Care Rapid Diagnosis sales for 2023 through 2029. With Point of Care Rapid Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point of Care Rapid Diagnosis industry.

This Insight Report provides a comprehensive analysis of the global Point of Care Rapid Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point of Care Rapid Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point of Care Rapid Diagnosis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point of Care Rapid Diagnosis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point of Care Rapid Diagnosis.

The global Point of Care Rapid Diagnosis market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Point of Care Rapid Diagnosis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Point of Care Rapid Diagnosis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Point of Care Rapid Diagnosis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Point of Care Rapid Diagnosis players cover Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux and Nova Biomedical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Point of Care Rapid Diagnosis market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Blood Glucose Testing
Blood Gas and Electrolytes Analysis
Rapid Coagulation Testing
Rapid Cardiac Markers Diagnostic
Drugs of Abuse Screening
Food Pathogens Screening
Hemoglobin Diagnostics
Infectious Disease Testing
Others

Segmentation by application
Clinics
Hospitals
Laboratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
Nova Biomedical
Trividia Health
Quidel
Accriva
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Trinity Biotech
ELITech Group
Response Biomedical
Princeton BioMeditech
Alfa Wassermann
ARKRAY

Key Questions Addressed in this Report

What is the 10-year outlook for the global Point of Care Rapid Diagnosis market?

What factors are driving Point of Care Rapid Diagnosis market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Point of Care Rapid Diagnosis market opportunities vary by end market size?

How does Point of Care Rapid Diagnosis break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.